Page last updated: 2024-10-27
gentamicin and Jaundice, Cholestatic
gentamicin has been researched along with Jaundice, Cholestatic in 1 studies
Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.
Research Excerpts
Excerpt | Relevance | Reference |
"With adequate drainage of the obstructed biliary tract by proper stenting, adding gentamicin to contrast media had no significant effect on incidence of post-ERCP cholangitis." | 9.17 | The effect of adding gentamicin to contrast media for prevention of cholangitis after biliary stenting for non-calculous biliary obstruction, a randomized controlled trial. ( Afroogh, R; Chaharmahali, M; Khatibian, M; Norouzi, A; Sotoudehmanesh, R, 2013) |
"With adequate drainage of the obstructed biliary tract by proper stenting, adding gentamicin to contrast media had no significant effect on incidence of post-ERCP cholangitis." | 5.17 | The effect of adding gentamicin to contrast media for prevention of cholangitis after biliary stenting for non-calculous biliary obstruction, a randomized controlled trial. ( Afroogh, R; Chaharmahali, M; Khatibian, M; Norouzi, A; Sotoudehmanesh, R, 2013) |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
Norouzi, A | 1 |
Khatibian, M | 1 |
Afroogh, R | 1 |
Chaharmahali, M | 1 |
Sotoudehmanesh, R | 1 |
Clinical Trials (1)
Trial Overview
Trial | Phase | Enrollment | Study Type | Start Date | Status |
Comparing Addition of Gentamicin vs. Placebo in Preventing Post ERCP Cholangitis in Non-calculus Stenting[NCT01148693] | | 114 participants (Actual) | Interventional | 2009-12-31 | Completed |
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Trial Outcomes
Number of Participants With Cholangitis
After Endoscopic Retrograde CholangioPancreatography (ERCP) in 3 following days we check all participants for syptoms of cholangitis (fever, chills, right upper qudrant (RUQ) pain, leukocytosis) and ruling out other diagnoses than cholangitis (NCT01148693)
Timeframe: 72 hours
Intervention | participants (Number) |
---|
Gentamicin | 5 |
Placebo | 5 |
Trials
1 trial available for gentamicin and Jaundice, Cholestatic